2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.
By Lauren Berg · April 9, 2025, 6:56 PM EDT
A split Second Circuit will allow Takeda Pharmaceuticals Co. to immediately appeal a New York federal judge's ruling certifying two classes of direct purchasers and end payors in consolidated antitrust actions...
To view the full article, register now.